This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AAIPharma Services And Cambridge Major Laboratories Appoint Eric Evans As CFO Of Merged Company

AAIPharma Services, Corp. (“AAI”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, announce the appointment of Eric Evans as the Chief Financial Officer (CFO) of the merged company (“AAI-CML”).

“Eric’s extensive financial experience in both the pharmaceutical and contract services sectors and his ability to work in a client-centered business structure make him a natural fit as chief financial officer of the merged company,” said Patrick Walsh, CEO of AAI-CML. “He brings leadership and experience managing contract development and manufacturing organizations through scalable growth.”

Evans brings more than 25 years of experience in financial leadership roles; most recently as chief financial officer of AAIPharma Services, Corp. Prior to AAIPharma, Evans was chief financial officer and executive vice president of Patheon, Inc. and vice president and controller for Novartis Pharmaceuticals. He was also chief financial officer for the U.S. division of Sandoz.

“I am excited about the potential that the merger brings for market leadership in end-to-end CMC services. I look forward to building on our strong foundation of proven capabilities to further establish the combined company’s leadership position in the growing pharmaceutical contract services market,” Evans said.

Evans earned his Master of Business Administration from Case Western Reserve University in Cleveland. He graduated from Queens University with a Bachelor of Arts and also earned a graduate degree from the University of Western Ontario, both in Canada.

AAI-CML is a premier global supplier of comprehensive CMC services, including process chemistry, solid state chemistry, API manufacturing, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid and sterile), packaging and stability services. The merged company is a portfolio company of American Capital, Ltd. (NASDAQ: ACAS).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs